Novel Excipients In Pharmaceutical Formulations: Current Trends And Future Perspectives

Excipients are non active substances included in pharmaceutical formulations to support the manufacturing process, enhance stability, and improve drug delivery. Although they do not possess therapeutic activity, they play a crucial role in ensuring the effectiveness, safety, and quality of medicines. Excipients help in improving flow properties, compressibility, solubility, and bioavailability of drugs, as well as ensuring uniform drug release and patient acceptability.In earlier times, excipients were simple materials such as starch, lactose, and talc, mainly used for basic formulation purposes. With advancements in pharmaceutical science, the role of excipients has evolved significantly. Modern formulations now require excipients with specialized and multifunctional properties to support complex drug delivery systems.However, conventional excipients often have limitations such as poor functionality, incompatibility with modern drugs, and inability to meet the needs of advanced delivery systems. The development of complex drugs like biologics and poorly water soluble compounds has increased the demand for innovative excipients. Additionally, the need for patient friendly formulations, especially for pediatric and geriatric patients, has further driven the development of improved excipient systems.[1,2]

CLASSIFICATION OF EXCIPIENTS

Excipients can be classified based on their function and source. Based on function, excipients include fillers or diluents that provide bulk to formulations, binders that impart cohesiveness, disintegrants that facilitate tablet breakdown, lubricants and glidants that improve flow and prevent sticking, coating agents that enhance stability and appearance, and solubilizers that improve drug dissolution. Based on source, excipients are categorized as natural, synthetic, and semi synthetic. Natural excipients are derived from plant, animal, or microbial sources such as starch and gelatin. Synthetic excipients are chemically produced and include polymers like polyethylene glycol. Semi synthetic excipients are modified natural substances such as cellulose derivatives that combine natural origin with enhanced functionality.[3]

Concept of Novel Excipients

Excipients are classified mainly based on two criteria: function and source.

Additional Functional Category:

→ Coating Agents → Protect and enhance stability

→ Solubilizers → Improve drug solubility and bioavailability

Novel excipients are defined as new chemical entities or materials not previously used in approved pharmaceutical products or existing excipients that have been significantly modified to improve performance. From a regulatory perspective, novel excipients require extensive safety and toxicological evaluation before approval.

A distinction exists between new chemical excipients and co processed excipients. New chemical excipients are entirely new substances, whereas co processed excipients are combinations of existing excipients processed together to achieve superior properties without chemical modification.

Novel excipients offer several advantages over conventional ones, including improved functionality, reduced variability, enhanced drug compatibility, and the ability to support advanced drug delivery systems.[4,5]

Figure 1. Classification of Pharmaceutical Excipients

TYPES OF NOVEL EXCIPIENTS

Novel excipients represent an advanced class of pharmaceutical additives designed to overcome the limitations of conventional excipients and meet the requirements of modern drug delivery systems. These excipients exhibit enhanced physicochemical properties, multifunctionality, and improved compatibility with active pharmaceutical ingredients. With the increasing complexity of drug molecules, particularly poorly water soluble drugs and biologics, the development of novel excipients has become essential. The major categories of novel excipients include co processed excipients, multifunctional excipients, smart stimuli responsive excipients, nanotechnology based excipients, and natural and modified biopolymers.

1. Co processed Excipients

Co processed excipients are formed by combining two or more existing excipients using physical processes such as spray drying, granulation, or melt extrusion. Unlike simple physical mixtures, co processed excipients are engineered to achieve superior performance by optimizing the properties of individual components without altering their chemical structure. The primary objective of co processing is to improve functional properties such as flowability, compressibility, dilution potential, and stability. These excipients are particularly beneficial in direct compression tablet formulations, where uniformity and mechanical strength are critical. One of the key advantages of co processed excipients is the synergistic effect obtained from combining different materials. For example, microcrystalline cellulose provides excellent compressibility, while lactose contributes to improved flow properties. When co processed, the resulting excipient exhibits enhanced performance compared to the individual components. Co processed excipients also reduce batch to batch variability and improve manufacturing efficiency. They eliminate the need for multiple excipients, thereby simplifying formulation design. Additionally, they enhance tablet hardness and reduce friability, which are important quality attributes. Despite their advantages, challenges such as scale up, cost, and regulatory acceptance need to be addressed for their widespread application.[6]

2. Multifunctional Excipients

Multifunctional excipients perform multiple roles in a single formulation, reducing the need for multiple components. This simplifies formulation design and improves efficiency. For instance, certain cellulose derivatives can act as both binders and disintegrants. Multifunctional excipients are designed to perform more than one role within a single formulation. These excipients represent a significant advancement in pharmaceutical technology, as they reduce the need for multiple individual excipients, thereby simplifying formulation development and manufacturing processes. Traditionally, different excipients are used for specific functions such as binding, disintegration, lubrication, and stabilization. However, the use of multifunctional excipients allows a single material to perform multiple roles simultaneously. This not only reduces formulation complexity but also improves consistency and reproducibility. For example, certain cellulose derivatives such as hydroxypropyl methylcellulose can function as both a binder and a controlled release agent. Similarly, some co processed excipients can act as fillers, binders, and disintegrants simultaneously. This multifunctionality leads to improved tablet integrity, faster disintegration, and enhanced drug release profiles. The use of multifunctional excipients offers several advantages, including reduced manufacturing steps, lower production costs, and improved product quality. These excipients are particularly useful in advanced drug delivery systems where multiple functionalities are required in a single dosage form. In addition, multifunctional excipients contribute to improved patient compliance by enabling the development of more efficient and user friendly dosage forms. They also facilitate the formulation of fixed dose combinations and complex drug delivery systems. However, the design and optimization of multifunctional excipients require a thorough understanding of material properties and interactions with active pharmaceutical ingredients.[7]

Fig. No. 2 Multifunctional Excipients

Table 2: Multifunctional Excipients with Examples

3. Smart Stimuli Responsive Excipients

These excipients respond to environmental stimuli such as pH, temperature, or enzymes. They enable targeted and controlled drug release. pH sensitive polymers release drugs in specific regions of the gastrointestinal tract, while temperature sensitive materials respond to body heat. Smart stimuli responsive excipients are advanced materials that respond to specific environmental triggers such as pH, temperature, enzymes, or light. These excipients are widely used in targeted and controlled drug delivery systems, where drug release is regulated based on physiological conditions. pH sensitive excipients are designed to release drugs in specific regions of the gastrointestinal tract. For example, enteric coatings remain intact in the acidic environment of the stomach and dissolve in the alkaline conditions of the intestine. Temperature sensitive excipients respond to changes in temperature, enabling controlled drug release at specific sites in the body. Enzyme responsive excipients are designed to release drugs in response to specific enzymes present in target tissues. This approach is particularly useful in targeted therapies such as cancer treatment, where selective drug delivery is essential. The major advantage of stimuli responsive excipients is their ability to provide site specific drug delivery, thereby reducing side effects and improving therapeutic efficacy. These excipients also enhance drug stability and allow precise control over drug release kinetics. Despite their potential, challenges such as complex synthesis, high cost, and regulatory hurdles must be addressed to facilitate their widespread adoption.[8]

Fig. No. 3 Smart Stimuli Responsive Excipients

4. Nanotechnology Based Excipients

Nanocarriers such as liposomes, nanoparticles, and dendrimers are used to improve drug solubility, stability, and targeting. Figure 1. Nanotechnology based excipients in drug delivery Description. This figure illustrates different nanocarriers such as liposomes and polymeric nanoparticles showing drug encapsulation and targeted delivery to specific tissues. Nanotechnology based excipients have revolutionized pharmaceutical formulation by enabling the development of advanced drug delivery systems. These excipients include nanocarriers such as liposomes, polymeric nanoparticles, solid lipid nanoparticles, and dendrimers. Nanocarriers improve drug solubility, stability, and bioavailability, particularly for poorly water soluble drugs. They also enable targeted drug delivery by directing the drug to specific tissues or cells. This reduces systemic side effects and enhances therapeutic outcomes. Liposomes are vesicular systems composed of lipid bilayers that encapsulate drugs, protecting them from degradation. Polymeric nanoparticles provide controlled and sustained drug release, while dendrimers offer precise molecular architecture for targeted delivery. Nanotechnology based excipients also play a crucial role in the delivery of biologics, vaccines, and gene therapies. They enhance drug permeability and facilitate crossing of biological barriers such as the blood brain barrier. However, issues related to toxicity, scalability, and regulatory approval need to be carefully considered.

5. Natural and Modified Biopolymers

Biopolymers such as chitosan, alginate, and cellulose derivatives are widely used due to their biodegradability and biocompatibility. Modified biopolymers offer enhanced properties such as improved solubility and controlled release. These materials also support the development of environmentally sustainable formulations. Natural and modified biopolymers are widely used as novel excipients due to their biodegradability, biocompatibility, and sustainability. These materials are derived from natural sources such as plants, animals, and microorganisms. Common examples include chitosan, alginate, and cellulose derivatives. Chitosan is widely used for its mucoadhesive properties and ability to enhance drug absorption. Alginate is used in controlled release formulations, while cellulose derivatives are extensively used in tablet and capsule formulations. Modified biopolymers are chemically altered to improve their properties such as solubility, mechanical strength, and stability. These modifications enable better control over drug release and enhance formulation performance The use of biopolymers also supports the development of environmentally friendly and sustainable pharmaceutical products. They are particularly suitable for green chemistry approaches and biodegradable formulations. Despite their advantages, variability in natural sources and potential microbial contamination remain challenges that need to be addressed.[9]

Table 5: Biopolymer Based Excipients

APPLICATIONS OF NOVEL EXCIPIENTS

Novel excipients play a crucial role in the advancement of modern pharmaceutical formulations by enabling the development of efficient and patient friendly drug delivery systems. In oral drug delivery, novel excipients are extensively used to achieve controlled drug release, taste masking, and solubility enhancement. They are particularly beneficial for poorly water soluble drugs, as they improve dissolution rate and bioavailability, thereby enhancing therapeutic effectiveness and patient compliance. In parenteral formulations, novel excipients act as stabilizers for sensitive biological molecules such as proteins and peptides, preventing degradation and maintaining their structural integrity. They also facilitate the development of advanced injectable delivery systems with improved stability and performance. In topical and transdermal systems, novel excipients function as penetration enhancers and film forming agents, allowing efficient drug permeation through the skin. This improves therapeutic efficacy and enables sustained drug release. Furthermore, novel excipients are widely used in advanced drug delivery systems, including targeted drug delivery, gene therapy, and vaccine delivery, where precise control over drug release and localization is essential.

• Oral Drug Delivery

Novel excipients are widely used in oral formulations to achieve controlled release, taste masking, and solubility enhancement. They improve the bioavailability of poorly soluble drugs and enhance patient compliance. Oral drug delivery remains the most widely used and preferred route of administration due to its convenience, cost effectiveness, and high patient compliance. However, many modern drugs, especially poorly water soluble compounds and biologics, present significant formulation challenges such as low solubility, poor bioavailability, and instability in the gastrointestinal tract. Novel excipients play a critical role in overcoming these challenges and enhancing the overall performance of oral formulations. One of the most important applications of novel excipients in oral drug delivery is controlled release. Controlled release systems are designed to deliver the drug at a predetermined rate, thereby maintaining optimal plasma drug concentration for an extended period. Novel excipients such as hydrophilic polymers, matrix formers, and multifunctional excipients are used to regulate drug release kinetics. These systems reduce dosing frequency and improve patient adherence to therapy. Another key application is taste masking, which is particularly important for pediatric and geriatric patients. Many drugs have an unpleasant taste that can reduce patient compliance. Novel excipients such as coating polymers, ion exchange resins, and complexing agents are used to mask the taste of drugs without affecting their therapeutic efficacy. Solubility enhancement is another major role of novel excipients in oral drug delivery. Poorly soluble drugs often exhibit low bioavailability due to limited dissolution in gastrointestinal fluids. Nanotechnology based excipients, solid dispersions, and surfactants improve drug solubility and dissolution rate, leading to enhanced absorption and bioavailability. In addition, novel excipients improve the stability of drugs in the gastrointestinal environment by protecting them from degradation due to pH variations and enzymatic activity. This is particularly important for sensitive molecules such as peptides and proteins. Overall, novel excipients significantly improve the efficiency, reliability, and patient acceptability of oral drug delivery systems.[10]

Fig. No. 4 Oral Drug Delivery

• Parenteral Formulation

In injectable formulations, novel excipients act as stabilizers for biologics and proteins, preventing degradation. They also facilitate the development of advanced injectable delivery systems. Parenteral drug delivery involves the administration of drugs through injections, such as intravenous, intramuscular, or subcutaneous routes. This route is widely used for drugs that are poorly absorbed orally, require rapid onset of action, or are sensitive to gastrointestinal degradation. However, parenteral formulations require a high level of stability, sterility, and safety. Novel excipients play a vital role in parenteral formulations, particularly in stabilizing biologics such as proteins, peptides, and monoclonal antibodies. These molecules are highly sensitive to environmental conditions and can undergo degradation through processes such as aggregation, denaturation, and oxidation. Stabilizing excipients such as sugars, amino acids, and polymers are used to maintain the structural integrity and biological activity of these molecules. Another important application is the development of advanced injectable delivery systems. Nanotechnology based excipients, including liposomes and polymeric nanoparticles, are widely used to encapsulate drugs and protect them from degradation. These systems also enable targeted drug delivery, reducing systemic toxicity and improving therapeutic efficacy. Novel excipients also contribute to improving solubility and preventing precipitation of drugs in injectable formulations. Surfactants and co solvents are commonly used to enhance drug solubility and ensure uniform distribution in the formulation. In addition, excipients play a role in controlling drug release from injectable formulations. Depot systems and sustained release injectables are developed using biodegradable polymers that gradually release the drug over time, reducing the need for frequent dosing. Overall, novel excipients enhance the stability, safety, and effectiveness of parenteral formulations, making them suitable for advanced therapeutic applications.[11,12]

Fig. No. 5 Parental Route

• Topical and Transdermal Systems

Novel excipients function as penetration enhancers and film forming agents in topical formulations. They improve drug permeation through the skin and enhance therapeutic effectiveness. Topical and transdermal drug delivery systems are designed to deliver drugs through the skin for local or systemic effects. These systems offer several advantages, including avoidance of first pass metabolism, sustained drug release, and improved patient compliance. However, the skin acts as a strong barrier, limiting drug penetration. Novel excipients are used as penetration enhancers to overcome this barrier and facilitate drug transport through the skin. These excipients alter the structure of the stratum corneum, increasing its permeability and allowing drugs to pass through more easily. Film forming excipients are another important component of topical formulations. These excipients form a thin film on the skin surface, ensuring uniform drug distribution and prolonged contact with the application site. This enhances drug absorption and therapeutic effectiveness. Novel excipients also enable controlled and sustained drug release in transdermal systems. Polymers and matrix systems are used to regulate the rate of drug release, maintaining consistent drug levels over time. In addition, nanotechnology based excipients such as nanoemulsions and lipid nanoparticles improve drug penetration and stability in topical formulations. These systems enhance drug delivery to deeper layers of the skin and improve therapeutic outcomes. Topical and transdermal systems are widely used for the treatment of dermatological conditions, pain management, and hormone therapy. The use of novel excipients in these systems significantly improves drug delivery efficiency and patient comfort.

Fig. No. 6 Topical and Transdermal Systems

ADVANCED DRUG DELIVERY SYSTEMS

They play a critical role in targeted drug delivery, gene therapy, and vaccine delivery. Applications of novel excipients in different drug delivery systems Description. The table summarizes various applications such as oral controlled release, injectable stabilization, and transdermal penetration enhancement along with corresponding excipient types.[13,14]

ADVANTAGES OF NOVEL EXCIPIENTS

Novel excipients significantly improve bioavailability by enhancing drug solubility and absorption. They reduce dose frequency through controlled release mechanisms and improve patient compliance. Additionally, they enhance stability and shelf life while increasing formulation efficiency by reducing the number of required components. Novel excipients provide several advantages over conventional excipients by significantly improving the performance of pharmaceutical formulations. They enhance drug bioavailability by improving solubility and absorption, which is particularly important for poorly soluble drugs. Controlled release properties of these excipients help reduce dosing frequency, thereby improving patient compliance. In addition, novel excipients improve the stability and shelf life of pharmaceutical products by protecting active ingredients from degradation. They also increase formulation efficiency by reducing the number of excipients required, leading to simplified manufacturing processes and improved product consistency. Overall, these advantages contribute to better therapeutic outcomes and enhanced patient acceptability.